The Drugs Controller General of India (DCGI) in a press conference at the National Media Centre approved the Oxford-AstraZeneca COVID-19 vaccine and Bharat Biotech’s Covaxin for emergency use on Sunday. Bharat BioTech’s Covaxin is India’s one of the first vaccines against the novel Coronavirus.
DCGI VG Somani said, “Both the drug firms have submitted data on their trial runs and both have been granted permission for “restricted use”. The overall efficacy of the Oxford-AstraZeneca COVID-19 vaccine was 70.42%, while Bharat Biotech’s Covaxin was “safe and provides a robust immune response.”
He added by saying that they’ll never approve anything if there is slightest of safety concern. The vaccines are 100% safe. Some side effects like mild fever, pain and allergy are common for every vaccine. It (people may get impotent) is absolute rubbish.
Prime Minister Narendra Modi congratulated the hardworking scientists and innovators in India after the vaccines received emergency approval,
A decisive turning point to strengthen a spirited fight!
DCGI granting approval to vaccines of @SerumInstIndia and @BharatBiotech accelerates the road to a healthier and COVID-free nation.
Congratulations India.
Congratulations to our hardworking scientists and innovators.
— Narendra Modi (@narendramodi) January 3, 2021
The country has been preparing for a COVID-19 vaccine rollout for the last four months.
